Study reinforces antiretroviral therapy’s effectiveness in HIV prevention
July 20th, 2010 - 3:16 pm ICT by ANILondon, July 20 (ANI): The benefits of highly active antiretroviral therapy (HAART) extend beyond treatment of the virus to significantly preventing the transmission and spread of HIV, according to new research.
The study, conducted by the BC Centre of Excellence in HIV/AIDS (BC-CfE), Vancouver, British Columbia, appears in the journal Lancet.
Recognized as the gold standard treatment for HIV, HAART uses a combination of drugs to stop HIV from progressing to AIDS, extends life expectancy, and significantly reduces HIV-related deaths in diagnosed individuals.
Gordon Campbell, Premier of British Columbia, said: “The expansion of HAART treatment plays an important role in the health of British Columbians with HIV, preventing HIV transmission and maximizing public health resources. Based on HAART’s effectiveness and ongoing research at the BC-CfE, Canada’s leading HIV/AIDS organization, the government of B.C. is investing in improving access to HAART through innovative programs such as the Seek and Treat initiative.”
The new study found that increased levels of HAART treatment were associated with a decrease in community viral load and in new HIV diagnoses across British Columbia, particularly in populations with a history of injection drug use.
Lead author and BC-CfE director Dr. Julio Montaner said: “These study results reinforce the effectiveness of HAART in preventing transmission of HIV, and support extending the treatment as prevention model developed at the BC-CfE and now being rolled out in major centres in Canada, the U.S. and elsewhere.”
Data resulting from BC-CfE research showed that the number of individuals actively receiving HAART had a strong impact on overall viral load and new diagnoses in the community. As HAART coverage increased, new HIV diagnoses decreased; as HAART coverage stabilized, so too did viral load and new HIV diagnoses.
The study results align with the emphasis global leaders in HIV research, policy and advocacy place on early treatment to prevent transmission of HIV. Michel Sidibé, Executive Director of UNAIDS, the Joint United Nations Programme on HIV/AIDS, noted that treatment is a smart health investment, as it reduces HIV transmission, TB infection and maternal and child mortality within communities, and improves work productivity.
He said: “The most recent evidence presented by the BC Centre for Excellence in HIV/AIDS and other leading research organizations supports these facts and tells us that we need to introduce treatment earlier. Treatment not only saves lives, it can be one of the most compelling prevention tools we have.” (ANI)
- New HIV prevention strategy to benefit sufferers by cutting costs - Jul 08, 2010
- Increased HAART coverage tied to 50pc drop among injection drug users - Feb 19, 2010
- 28,000 die of HIV/AIDS in China - Jan 22, 2012
- Aid appeal to combat HIV/AIDS in Myanmar - Dec 06, 2011
- Mother-to-child HIV transmission on decline in US, but more can be done - Jul 23, 2010
- Treating HIV-AIDS with interleukin-2 'ineffective' - Oct 16, 2009
- Integrate Hepatitis C testing with HIV: NGOs - Oct 21, 2011
- Priority is to up collaborative TB-HIV activities - Jul 19, 2010
- Court notice on insurance for AIDS patients - May 12, 2011
- Scientists working to develop model of HIV/AIDS care for developing nations - Dec 23, 2009
- India to avert 3 million HIV cases: World Bank - Nov 30, 2011
- AIDS drugs block 99pc of HIV transmission to breastfed babies - Jun 17, 2010
- Kicking tobacco habit amongst HIV patients - Jun 04, 2010
- Meet on AIDS begins at UN - Jun 08, 2011
- Aim to eliminate HIV-AIDS from South-East Asia by 2015: WHO (Dec 1 is World AIDS Day) - Nov 30, 2011
Tags: aids organization, bc centre, british columbians, centre of excellence, cfe, global leaders, gordon campbell, hiv aids, hiv diagnoses, hiv haart, hiv prevention, hiv transmission, innovative programs, journal lancet, ongoing research, premier of british columbia, public health resources, transmission of hiv, vancouver british columbia, viral load